James R. Stone

ORCID: 0000-0001-9122-3311
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Aerodynamics and Acoustics in Jet Flows
  • Education Systems and Policy
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • IgG4-Related and Inflammatory Diseases
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Acoustic Wave Phenomena Research
  • Neuroendocrine Tumor Research Advances
  • Traumatic Brain Injury Research
  • Vasculitis and related conditions
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Fibroblast Growth Factor Research
  • COVID-19 Clinical Research Studies
  • Diverse Educational Innovations Studies
  • Cardiac Structural Anomalies and Repair
  • Management and Marketing Education
  • Aortic aneurysm repair treatments
  • Combustion and flame dynamics
  • Lung Cancer Research Studies
  • Abdominal vascular conditions and treatments
  • Vehicle Noise and Vibration Control
  • Gastrointestinal disorders and treatments
  • Higher Education and Employability
  • Computational Fluid Dynamics and Aerodynamics
  • Eosinophilic Disorders and Syndromes

University of Virginia
2014-2025

Massachusetts General Hospital
2015-2024

Harvard University
2015-2024

Beth Israel Deaconess Medical Center
2024

University of British Columbia
2024

Dalhousie University
2024

National Clinical Research
2024

Chinese Academy of Medical Sciences & Peking Union Medical College
2024

The University of Texas Health Science Center at Houston
2023

Stone Clinic
2023

PD-1 inhibitors are established agents in the management of non-small cell lung cancer (NSCLC); however, only a subset patients derives clinical benefit. To determine activity PD-1/PD-L1 within clinically relevant molecular subgroups, we retrospectively evaluated response patterns among EGFR-mutant, anaplastic lymphoma kinase (ALK)-positive, and EGFR wild-type/ALK-negative patients.We identified 58 treated with inhibitors. Objective rates (ORR) were assessed using RECIST v1.1. PD-L1...

10.1158/1078-0432.ccr-15-3101 article EN Clinical Cancer Research 2016-05-26
Toni Delorey Carly G.K. Ziegler Graham Heimberg Rachelly Normand Yiming Yang and 95 more Åsa Segerstolpe Domenic Abbondanza Stephen J. Fleming Ayshwarya Subramanian Daniel T. Montoro Karthik A. Jagadeesh Kushal K. Dey Pritha Sen Michal Slyper Yered Pita-Juárez Devan Phillips Jana Biermann Zohar Bloom‐Ackermann Nikolaos Barkas Andrea Ganna James Gomez Johannes C. Melms Igor Katsyv Erica Normandin Pourya Naderi Yeganeh Yury Popov Siddharth S. Raju Sebastian Niezen Linus Tsai Katherine J. Siddle Malika Sud Victoria M. Tran Shamsudheen Karuthedath Vellarikkal Yiping Wang Liat Amir-Zilberstein Deepak Atri Joseph Beechem Olga R. Brook Jonathan Chen Prajan Divakar Phylicia Dorceus J Engreitz Adam L. Essene Donna M. Fitzgerald Robin Fropf Steven Gazal Joshua Gould John Grzyb Tyler Harvey Jonathan L. Hecht Tyler Hether Judit Jané‐Valbuena Michael Leney-Greene Hui Ma Cristin McCabe Daniel E. McLoughlin Eric Miller Christoph Muus Mari Niemi Robert F. Padera Liuliu Pan Deepti Pant Carmel Pe’er Jenna Pfiffner-Borges Christopher J. Pinto Jacob Plaisted Jason Reeves Marty Ross Melissa A. Rudy Erroll H. Rueckert Michelle Siciliano Alexander Sturm Ellen Todres Avinash Waghray Sarah Warren Shuting Zhang Daniel R. Zollinger Lisa A. Cosimi Rajat M. Gupta Nir Hacohen Hanina Hibshoosh Yoshihide Hayashizaki Alkes L. Price Jayaraj Rajagopal Purushothama Rao Tata Stefan Riedel Gyöngyi Szabó Timothy L. Tickle Patrick T. Ellinor Deborah T. Hung Pardis C. Sabeti Richard Novák Robert Rogers Donald E. Ingber Z. Gordon Jiang Dejan Juric Mehrtash Babadi Samouil L. Farhi Benjamin Izar James R. Stone

10.1038/s41586-021-03570-8 article EN other-oa Nature 2021-04-29

John H. Stone, Arezou Khosroshahi, Vikram Deshpande, K. C. Chan, J. Godfrey Heathcote, Rob Aalberse, Atsushi Azumi, Donald B. Bloch, William R. Brugge, Mollie N. Carruthers, Wah Cheuk, Lynn Cornell, Carlos Fernandez-Del Castillo, Judith A. Ferry, David Forcione, Gunter Kloppel, Daniel L. Hamilos, Terumi Kamisawa, Satomi Kasashima, Shigeyuki Kawa, Mitsuhiro Kawano, Yasufumi Masaki, Kenji Notohara, Kazuichi Okazaki, Ji Kon Ryu, Takako Saeki, Dushyant Sahani, Yasuharu Sato, Thomas Smyrk, James...

10.1002/art.34593 article EN Arthritis & Rheumatism 2012-06-26

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSoluble Guanylate Cyclase from Bovine Lung: Activation with Nitric Oxide and Carbon Monoxide Spectral Characterization of the Ferrous Ferric StatesJames R. Stone Michael A. MarlettaCite this: Biochemistry 1994, 33, 18, 5636–5640Publication Date (Print):May 10, 1994Publication History Published online1 May 2002Published inissue 10 1994https://pubs.acs.org/doi/10.1021/bi00184a036https://doi.org/10.1021/bi00184a036research-articleACS...

10.1021/bi00184a036 article EN Biochemistry 1994-05-10

Background The mechanisms of extracellular matrix changes accompanying myxomatous valvular degeneration are uncertain. Methods and Results To test the hypothesis that interstitial cells mediate degradation in by excessive secretion catabolic enzymes, we examined functional characteristics 14 mitral valves removed for from patients with regurgitation 11 normal obtained at autopsy. Immunohistochemical staining assessed (1) cell phenotype using antibodies to α-actin (microfilaments), vimentin...

10.1161/hc4601.099489 article EN Circulation 2001-11-20

Genetic alterations in the fibroblast growth factor receptor (FGFR) pathway are promising therapeutic targets many cancers, including intrahepatic cholangiocarcinoma (ICC). The FGFR inhibitor BGJ398 displayed encouraging efficacy patients with FGFR2 fusion-positive ICC a phase II trial, but durability of response was limited some patients. Here, we report molecular basis for acquired resistance to three via integrative genomic characterization cell-free circulating tumor DNA (cfDNA), primary...

10.1158/2159-8290.cd-16-1000 article EN Cancer Discovery 2016-12-30

IgG4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serologic, radiologic, and pathologic data is required for diagnosis. This work was undertaken to develop validate an international set of classification criteria IgG4-RD.An multispecialty group 86 physicians assembled by the American College Rheumatology (ACR) European League Against Rheumatism (EULAR). Investigators used consensus exercises, existing literature, derivation...

10.1002/art.41120 article EN Arthritis & Rheumatology 2019-12-02

Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been associated with cardiovascular features of myocardial involvement including elevated serum troponin levels and heart failure reduced ejection fraction. The cardiac pathological changes in these patients COVID-19 have yet be well described.In an international multicentre study, tissue from the autopsies 21 consecutive was assessed by pathologists. presence myocarditis, as defined...

10.1093/eurheartj/ehaa664 article EN other-oa European Heart Journal 2020-08-04

Objective The development of practice parameters for intravenous analgesia and sedation adult patients in the intensive care unit (ICU) setting purpose guiding clinical practice. Participants A task force more than 40 experts disciplines related to use analgesic sedative agents ICU was convened from membership American College Critical Care Medicine (ACCM) Society (SCCM). Evidence members provided personal experience determined published literature (MEDLINE articles, textbooks,...

10.1097/00003246-199509000-00021 article EN Critical Care Medicine 1995-09-01

Crizotinib, an inhibitor of anaplastic lymphoma kinase (ALK), has also recently shown efficacy in the treatment lung cancers with ROS1 translocations. Resistance to crizotinib developed a patient metastatic adenocarcinoma harboring CD74-ROS1 rearrangement who had initially dramatic response treatment. We performed biopsy resistant tumor and identified acquired mutation leading glycine-to-arginine substitution at codon 2032 domain. Although this does not lie gatekeeper residue, it confers...

10.1056/nejmoa1215530 article EN New England Journal of Medicine 2013-06-01

IgG4-related disease (IgG4-RD) is a heterogeneous, multiorgan condition of unclear aetiology that can cause organ failure. Difficulty recognising IgG4-RD contributes to diagnostic delays. We sought identify key phenotypes.We used two cross-sectional studies assembled by an international, multispecialty network specialists who submitted 765 cases derive and replicate phenotypic groups. Phenotype groups manifestations covariate distributions across the identified were measured using latent...

10.1136/annrheumdis-2018-214603 article EN Annals of the Rheumatic Diseases 2019-01-05

Abstract Aims Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data exist on the use cardiovascular magnetic resonance (CMR) in ICI-associated myocarditis. In this study, CMR characteristics and association between features events among patients with myocarditis are presented. Methods results From an international registry myocarditis, clinical, CMR, histopathological findings were collected. Major adverse (MACE) composite death, cardiogenic...

10.1093/eurheartj/ehaa051 article EN European Heart Journal 2020-01-21

The interleukin-6 pathway is up-regulated in giant cell arteritis (GCA), Takayasu (TA), and polymyalgia rheumatica (PMR). We retrospectively assessed the outcomes of 10 patients with relapsing/refractory GCA, TA, or PMR treated tocilizumab (TCZ).Patients GCA (n = 7), TA 2), 1) received TCZ. Seven subjects had failed at least 1 second-line agent. evaluated were symptoms disease activity, inflammatory markers, ability to taper glucocorticoids, cross-sectional imaging when indicated...

10.1002/acr.21750 article EN Arthritis Care & Research 2012-06-05
Coming Soon ...